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EDITORIALS
Screening for disease is one of the cornerstones of 
medicine and public health, used to help make a 
diagnosis in individuals presenting with suggestive 
clinical signs and symptoms, and to find early signs 
of disease in high-risk groups such as tuberculosis in 
miners and pre-eclampsia in pregnant women. In addition, community-
based screening for chronic diseases is becoming a regular part of 
healthcare systems in middle- and high-income countries. This has been 
defined as ‘the systematic application of a test or enquiry to identify 
individuals at sufficient risk of a specific disorder to benefit from further 
investigation or direct preventive action, among people who have not 
sought medical attention because of symptoms of that disorder’.[1] The 
concepts and principles of screening have been well documented in the 
past, with criteria established for deciding on whether a population-
wide screening service should be developed and some of the challenges 
related to this.[2] In particular, the disease must be well defined, of 
known prevalence, and amenable to treatment or prevention. The test 
to be used should be simple and safe, and the distribution of test values 
in affected and unaffected individuals known. The screening service 
should be cost-effective and available to those who should be covered. 
The procedures following a positive result should be agreed on and 
acceptable to both those providing the service and those to be screened. 
There should be equity of access to the service, and it should form part of 
a comprehensive set of services aimed at preventing, treating and caring 
for those who have the disorder being screened for. Most of these services 
need to be embedded in primary healthcare settings.[3]
A recent review of screening for chronic diseases in South Africa 
in an insured population, published in this issue of SAMJ, shows the 
magnitude of the challenge of developing an effective set of services 
for the country.[4] Even in this relatively wealthy, well-served group 
uptake of services was low, and the outcome of the service as a whole 
is not known or available for review. Given this low uptake, and the 
likelihood that those least likely to benefit from the service are those 
most likely to use it, the impact of current services is probably small. 
In the majority of the population, who do not have private insurance 
but who probably have the biggest burden of diseases, coverage in 
most situations will probably be worse. As the country moves towards 
universal coverage of services under National Health Insurance, there 
are major questions to be resolved about the role that community-
based screening for chronic diseases will play, and the priorities for 
services to be developed across the country.
South Africa will need to decide on what screening services are required 
and for who, based on its own pattern of disease burden, as has already 
started with routine HIV counselling and testing (HCT). However, 
there is value in looking at the experiences of other countries, both in 
terms of policies and the evidence behind them. For example, the US 
Preventive Services Task Force is an independent group that reviews the 
evidence on screening and other preventive services and makes regular 
recommendations to government.[5] These recommendations are then 
used to provide extensive guidance to care providers through groups 
such as the American Academy of Family Physicians.[6] For example, this 
group recommends screening for alcohol misuse in adults in primary care 
settings, breast cancer in women over 50, cervical cancer in women aged 21 
- 65, colorectal cancer in adults aged 50 - 75, hypertension in those 18 and 
above and adult obesity, but advises against screening for type 2 diabetes in 
asymptomatic adults with normal blood pressure, and for prostatic cancer 
using prostate-specific antigen (PSA). Similar agencies provide reviews 
and recommendations in the UK[7] and Australia.[8]
As in other parts of the world, chronic and non-communicable 
diseases are increasing in South Africa.[9] The government is already 
building on the progress it has made with tobacco by further reducing 
the future burden through regulation of salt and trans-fatty acid content 
in food, and banning advertising of alcohol to children. These efforts to 
promote health and prevent ill health could in future be complemented 
by more systematic community-based screening. The successes in the 
HCT campaign provide a good starting point, and the inclusion of 
tests for some non-communicable diseases provides useful lessons for 
future national screening policies. As South Africa introduces National 
Health Insurance, guidance and recommendations will be required 
to guide national policy and the further development of screening 
services. There are a large number of options that could be developed, 
and an increasing number of commercially available screening tests. 
As in other countries, independent experts will be required to advise 
on priorities, screening tests, evaluations of screening coverage and 
outcomes, and to provide up-to-date guidance for service providers.
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